Does the US have a drug innovation problem?

Health Affairs This Week

Does the US have a drug innovation problem?

Listen to Health Affairs' Jessica Bylander and Rob Lott explore whether the US has a drug innovation problem or not.
May 28, 2021

Does the US have a drug innovation problem?

Last week, Representative Katie Porter took AbbVie CEO Richard Gonzalez to task on drug pricing during a House Oversight and Reform Committee hearing. Porter highlighted the CEO’s high salary while pointing to increases in drug prices in the pharmaceutical industry.

The narrative casts pharmaceutical companies as villains but it’s more complicated than that. It’s true that pharmaceutical companies provide life-saving medicines and it’s also true that some drugs simply aren’t affordable for individuals that would benefit from them.

 On this episode of Health Affairs This Week, Senior Editor Jessica Bylander joins Deputy Editor Rob Lott to discuss the inherent tensions in drug innovation and pricing.

Related Links:

Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

How Can Healthcare Workers Care for Themselves and Colleagues During Times of Grief Part 2 of 2: Practical Tools and Methods to Help Process Loss